Floatz logo

Rizatriptan

Migraine With Aura

Diamond Headache ClinicSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Migraine With Aura cohort.

Asset / SponsorPhaseRating
Topamax
Tongji Hospital
Phase 4BBB
PROPRANOLOL
Norwegian University of Science and Technology
Phase 3BB
Dihydroergotamine mesylate
Satsuma Pharmaceuticals, Inc.
Phase 3BB
Rimegepant
University of South Florida
Phase 4BB
ALMOTRIPTAN
Messoud Ashina, MD
Phase 4BB

View all 49 →

Same molecule, other indications

Rizatriptan is also rated in:

migraine disorderDormant
A
Indicative ·
80 / 100
View asset →
migraine without auraDormant
B
Indicative ·
62 / 100
View asset →
Migrainous VertigoDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →